These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1178922)

  • 61. [Effectiveness of selective anti-measles reimmunization of risk-group children].
    Sokhin AA; Ignatov SA
    Pediatriia; 1988; (9):69-72. PubMed ID: 3200643
    [No Abstract]   [Full Text] [Related]  

  • 62. [Revaccination of children inoculated against measles].
    Bolotovskiĭ VM; Titova NS; Bakhur EA; Tamm OM; Miartin IaK
    Pediatriia; 1981 Dec; (12):46-8. PubMed ID: 7335425
    [No Abstract]   [Full Text] [Related]  

  • 63. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.
    Norrby E; Enders-Ruckle G; Meulen V
    J Infect Dis; 1975 Sep; 132(3):262-9. PubMed ID: 1159329
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
    Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Measles vaccination in Zaïre--when and how?
    Wood PB; Soheranda KS; Bracken PM; Houser NE
    Trans R Soc Trop Med Hyg; 1980; 74(3):381-2. PubMed ID: 7434432
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Editorial: Vaccination against measles.
    Lancet; 1976 Jul; 2(7977):132-4. PubMed ID: 59191
    [No Abstract]   [Full Text] [Related]  

  • 67. Live measles vaccine from a further attenuated strain SEVAC.
    Mares I; Drevo M; Adam E; Kubátová M; Casny J
    Prog Immunobiol Stand; 1967; 3():188-91. PubMed ID: 5379938
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinico-laboratory and seroepidemiological examinations of children immunized with live measles vaccine prepared from genetically homogeneous strain Moscow-5].
    Unanov SS; Iuminova NV; Pasechnik AL; Sokolova AF; Gordienko NM
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):49-54. PubMed ID: 4072497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The distribution of complement fixing antibodies against measles virus in a sample of population in Emilia-Romagna (author's transl)].
    Re MC; Mazzaracchio R; Nanetti A
    Ann Sclavo; 1980; 22(2):141-6. PubMed ID: 7469536
    [No Abstract]   [Full Text] [Related]  

  • 70. Measles vaccines.
    Dudgeon JA
    Br Med Bull; 1969 May; 25(2):153-8. PubMed ID: 4918530
    [No Abstract]   [Full Text] [Related]  

  • 71. [An analysis of the efficacy of measles vaccination].
    Su SC; Hwang KP; Huang JI; Lu CC; Lai HL; Lin KH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1988 Mar; 4(3):192-8. PubMed ID: 3163020
    [No Abstract]   [Full Text] [Related]  

  • 72. [Serologic indices of measles immunity in children exposed to measles].
    Tikhonova NT; Khrometskaia TM; Ignat'eva GV; Gerasimova AG; Livanova LV
    Vopr Virusol; 1974; 19(0):357-63. PubMed ID: 4837951
    [No Abstract]   [Full Text] [Related]  

  • 73. [Vaccination against measles in children under and over 1 year of age].
    Midulla M; Balducci L; Assensio AM; Menichella V; Sebastiani M; Sabatino G
    Minerva Pediatr; 1976 Dec; 28(39):2425-8. PubMed ID: 1012247
    [No Abstract]   [Full Text] [Related]  

  • 74. The sero-epidemiology of measles in Rwanda.
    De Mol P; Bosmans E; Zissis G
    Acta Paediatr Belg; 1978; 31(1):61. PubMed ID: 665238
    [No Abstract]   [Full Text] [Related]  

  • 75. Live measles vaccine: a 21 year follow up.
    Miller C
    Br Med J (Clin Res Ed); 1987 Jul; 295(6589):22-4. PubMed ID: 3113599
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Chromosome breaks and changes in the mitotic regime of human and animal cells under the influence of a measles virus vaccinal strain (L-16)].
    Il'inskikh NN
    Tsitologiia; 1975 Feb; 17(2):131-6. PubMed ID: 1170661
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Letter: Measles immunity and revaccination.
    Balfour HH; Quie PG; Kalis JM
    JAMA; 1976 May; 235(19):2079. PubMed ID: 946524
    [No Abstract]   [Full Text] [Related]  

  • 78. Measles vaccine failure after documented seroconversion.
    Reyes MA; de Borrero MF; Roa J; Bergonzoli G; Saravia NG
    Pediatr Infect Dis J; 1987 Sep; 6(9):848-51. PubMed ID: 3670952
    [No Abstract]   [Full Text] [Related]  

  • 79. Response to live attenuated measles vaccine in children with severe kwashiorkor.
    Powell GM
    Ann Trop Paediatr; 1982 Sep; 2(3):143-5. PubMed ID: 6191631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [New methods on the measles prophylaxis (author's transl)].
    de Blasi R; Fazio-Gentile G
    Ann Sclavo; 1979; 21(2):113-59. PubMed ID: 485597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.